75.24
2.38%
1.75
Dopo l'orario di chiusura:
75.24
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Haemonetics Corp Borsa (HAE) Ultime notizie
Completion of Whole Blood Assets Sale to GVS Likely to Boost HAE Stock - Yahoo Finance
Haemonetics (NYSE:HAE) Reaches New 1-Year LowHere's Why - MarketBeat
Haemonetics stock hits 52-week low at $70.1 amid challenges - MSN
Haemonetics (NYSE:HAE) Shares Down 3.2%Here's What Happened - MarketBeat
Haemonetics Co. (NYSE:HAE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Haemonetics Completes $67.8 Million Sale of Whole Blood Assets to GVS – Market - HPBL
Haemonetics Sells Whole Blood Assets to GVS for $67.8M, Focuses on Core Apheresis Business - StockTitan
Haemonetics Sets Q3 FY2025 Earnings Call for February 6Financial Results Preview - StockTitan
Why Haemonetics (HAE) is a Top Value Stock for the Long-Term - Yahoo Finance
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference - Quantisnow
Haemonetics Co. (NYSE:HAE) Short Interest Up 7.4% in December - MarketBeat
Principal Financial Group Inc. Sells 37,433 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
Principal Financial Group Inc. Has $12.48 Million Holdings in Haemonetics Co. (NYSE:HAE) - Defense World
HighTower Advisors LLC Sells 556 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
Here's Why You Should Add HAE Stock to Your Portfolio Now - Yahoo Finance
Down -11.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Haemonetics (HAE) - Yahoo Finance
Haemonetics Co. (NYSE:HAE) Shares Purchased by Stifel Financial Corp - Defense World
Analysts Set Haemonetics Co. (NYSE:HAE) PT at $108.78 - MarketBeat
Investors three-year returns in Haemonetics (NYSE:HAE) have not grown faster than the company's underlying earnings growth - Yahoo Finance
Haemonetics Co. (NYSE:HAE) Position Lifted by Geode Capital Management LLC - MarketBeat
Zacks Research Predicts Haemonetics’ Q4 Earnings (NYSE:HAE) - Defense World
Zacks Research Forecasts Haemonetics' Q4 Earnings (NYSE:HAE) - MarketBeat
Zacks Research Forecasts Higher Earnings for Haemonetics - MarketBeat
Platelet Aggregation Devices Market Overall Study Report - openPR
BNP Paribas Financial Markets Has $1.36 Million Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Fmr LLC Has $62.26 Million Stake in Haemonetics Co. (NYSE:HAE) - MarketBeat
The Manufacturers Life Insurance Company Sells 248,835 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
JPMorgan sets Haemonetics stock overweight with $116 target By Investing.com - Investing.com Nigeria
Settlement checks in the mail from Vizio, Haemonetics - Top Class Actions
Are Investors Undervaluing Haemonetics (HAE) Right Now? - Yahoo Finance
JPMorgan sets Haemonetics stock overweight with $116 target - Investing.com India
Haemonetics (NYSE:HAE) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat
Haemonetics (HAE) Shares Cross Below 200 DMA - Nasdaq
Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios - Yahoo Finance
Holocene Advisors LP Takes $5.42 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
The Latest Analyst Ratings For Haemonetics - Inkl
Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High? - Yahoo Finance
Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS? - Yahoo Finance
7,746 Shares in Haemonetics Co. (NYSE:HAE) Purchased by Paloma Partners Management Co - MarketBeat
Haemonetics to offload whole-blood business for up to $67M - Yahoo Finance
Haemonetics stock still a Buy as Whole Blood sale aligns with margin improvement efforts - Investing.com
Atom Investors LP Takes $1.57 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
Bridgewater Associates LP Has $629,000 Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A - PR Newswire
Q3 EPS Estimates for Haemonetics Lowered by Zacks Research - MarketBeat
Zacks Research Decreases Earnings Estimates for Haemonetics - Defense World
Isthmus Partners LLC Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Citigroup Inc. Sells 5,678,717 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Co. (NYSE:HAE) Shares Purchased by Loomis Sayles & Co. L P - MarketBeat
Intech Investment Management LLC Boosts Stake in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Co. (NYSE:HAE) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Eagle Asset Management Inc. Sells 118,636 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
Westfield Capital Management Co. LP Has $66.21 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Co. (NYSE:HAE) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Leukapheresis Market 2024 Opportunity, Challenge, Drivers, - openPR
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):